Screening to identify unsuitable candidates for ipilimumab in advanced melanoma

Nivolumab alone superior to ipilimumab alone in advanced melanoma

Adjuvant denosumab may preserve bone health in postmenopausal breast cancer patients: results of the ABCSG-18 trial

Initial nivolumab-based treatment halts melanoma progression

Advanced DNA sequencing test used to match rare cancers

Dasatinib plus intensive chemo versus stem cell transplant for Philadelphia chromosome positive ALL

Raloxifene retained approximately 81% of the effectiveness of tamoxifen in preventing invasive breast cancer

Next generation inhibitors help overcome problems of resistance in ALK positive lung cancer

Letrozole vs observation for HR positive breast cancer

Phase III study finds initial nivolumab-based treatment halts melanoma progression

Ibrutinib combination regimen shows substantial benefits in relapsed CLL

Using the FALCON contouring platform to improve radiation oncologists' technique